PR Newswire
BOSTON, Oct. 26, 2017
BOSTON, Oct. 26, 2017 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP) ("Juniper" or the "Company"), will hold a conference call on November 2, 2017, to discuss the financial results for the third quarter ended September 30, 2017, as follows:
Date: | Thursday, November 2, 2017 |
Time: | 4:30 p.m. |
Dial-in numbers: | Toll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or |
| International: (1-412-902-4218) |
Audio webcast (live & archive): www.juniperpharma.com, under 'Investors' or click here.
The teleconference replay will be available approximately one hour after completion through Thursday, November 9, 2017, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10113476.
The archived webcast will be available for one year via the aforementioned URLs.
About Juniper Pharmaceuticals
Juniper Pharmaceuticals, Inc. core businesses include its CRINONE® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients. The Company is also leveraging its differentiated intravaginal ring technology, which offers the potential to address unmet needs in women's health. Please visit www.juniperpharma.com for more information.
Juniper Pharmaceuticals™ is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU.
Crinone® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan, Inc. in the U.S.
Investor Contact:
Laura Perry or Heather Savelle
Argot Partners
212-600-1902
To receive Juniper's press releases, SEC filings or calendar alerts by email click here.
Follow us on LinkedIn
View original content with multimedia:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-report-third-quarter-2017-results-on-november-2-2017-300544619.html
SOURCE Juniper Pharmaceuticals, Inc.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.